Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
Journal of Medical Virology|July 10, 2019
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimensNicola Gianotti, Camilla Muccini, Laura Galli, et al.
Cytometry. Part B, Clinical Cytometry|September 27, 2005
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settingsSilva Barbesti, Laura Soldini, Guisline Carcelain, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 2, 2009
Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruptionCristina Mussini, Giota Touloumi, Giorgos Bakoyannis, et al.
Blood|March 9, 2006
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progressionClaudia Pastori, Barbara Weiser, Claudia Barassi, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2007
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progressionGiulia Morsica, Sabrina Bagaglio, Silvia Ghezzi, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
Journal of Medical Virology|July 10, 2019
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimensNicola Gianotti, Camilla Muccini, Laura Galli, et al.
Cytometry. Part B, Clinical Cytometry|September 27, 2005
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settingsSilva Barbesti, Laura Soldini, Guisline Carcelain, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 2, 2009
Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruptionCristina Mussini, Giota Touloumi, Giorgos Bakoyannis, et al.
Blood|March 9, 2006
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progressionClaudia Pastori, Barbara Weiser, Claudia Barassi, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2007
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progressionGiulia Morsica, Sabrina Bagaglio, Silvia Ghezzi, et al.
Pageof 29